80 likes | 180 Vues
This paper by Matthew Herder explores the complexities of intellectual property (IP) as it relates to stem cell research and its commercialization across various regions, including Canada, Europe, the United States, Japan, China, and Australia. The analysis covers key issues such as patentability, the implications of the Bayh-Dole Act, and potential models for commercialization. By examining the interplay between IP, competition, and innovation in the field of stem cells, this work highlights the challenges researchers face in navigating the international landscape.
E N D
Intellectual Propertyand theInternationalCompetitiveContext: matthew herder Stem Cells & Meta/Half-Truths
1st meta/half-truth IP innovation
2nd meta/half-truth harmony IP
3rd meta/half-truth IP competition
stem cells canada europe us japan china australia patentability?
stem cells us china india bayh-dole importation?
stem cells aggtx canada UK sc4sm cscc california models of commercialization?